Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ELL
|
|||
| Former ID |
DAP000848
|
|||
| Drug Name |
Amisulpride
|
|||
| Synonyms |
Aminosultopride; Amisulpiride; Amisulprida; Amisulpridum; Deniban; Socian; Solian; Amisulpride [INN]; DAN 2163; Amisulprida [INN-Spanish]; Amisulpride (INN); Amisulpridum [INN-Latin]; DAN-2163; Deniban (TN); Solian (TN); Solian, Amisulpride; SL-91.1077; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-anisamid; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide; 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Approved | [1], [2] | |
| Therapeutic Class |
Antipsychotic Agents
|
|||
| Company |
Sanofi-Aventis
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H27N3O4S
|
|||
| Canonical SMILES |
CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC
|
|||
| InChI |
1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)
|
|||
| InChIKey |
NTJOBXMMWNYJFB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 71675-85-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
4426036, 7978690, 8151467, 12013930, 14852985, 24890689, 26719747, 26719748, 26753203, 29221338, 46386656, 46386793, 49681614, 49875487, 50105670, 50740420, 51091647, 56311657, 57321177, 81041117, 81092862, 85208948, 85789065, 90341703, 91746200, 92308440, 92721951, 99437236, 99443244, 103527296, 104299778, 117878946, 121361831, 124658864, 124757136, 124801322, 124891581, 125001904, 125163940, 125312444, 125356672, 126592345, 126618690, 126660738, 126665652, 128751968, 131324616, 131342364, 131480773, 131849879
|
|||
| ChEBI ID |
CHEBI:64045
|
|||
| ADReCS Drug ID | BADD_D00117 | |||
| SuperDrug ATC ID |
N05AL05
|
|||
| SuperDrug CAS ID |
cas=071675859
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 963). | |||
| REF 2 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
| REF 3 | Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20(5):389-409. | |||
| REF 4 | Amisulpride: a review of its use in the management of schizophrenia. CNS Drugs. 2004;18(13):933-56. | |||
| REF 5 | Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.